The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Liquid biopsy-based assays to monitor residual disease in cancer.
Gangwu Mei
Employment or Leadership Position - Guardant Health
Stock Ownership - Guardant Health
Dragan Sebisanovic
Employment or Leadership Position - Guardant Health
Stock Ownership - Guardant Health
Alain Mir
Employment or Leadership Position - Guardant Health
Stock Ownership - Guardant Health
Zulfiqar Gulzar
Consultant or Advisory Role - Guardant Health
James D. Brooks
Consultant or Advisory Role - Guardant Health (U)
Stock Ownership - Guardant Health
Stefanie S. Jeffrey
No relevant relationships to disclose
AmirAli Talasaz
Employment or Leadership Position - Guardant Health
Stock Ownership - Guardant Health